Healthcare careers for chemists are once again largely based in laboratories, although increasingly there is opportunity to work at the point of care, helping with patient investigation. In a patent, 2682-49-7, name is Thiazolidin-2-one, introducing its new discovery. Electric Literature of 2682-49-7
Thiazolidinone and its derivatives have high pharmacological relevance since they are available in both natural products and Pharmaceutical compounds. The main synthetic routes to thiazolidinones comprising three components such as an amine, a carbonyl group and mercapto acid. The classical method of synthesis reported may be either a one-pot three-component condensation method or a two-step process. Synthesis and anticancer activity evaluation of thiazolidinones containing benzothiazole moiety. These compounds were screened for in-vitro anticancer activity. The activity data exhibits that all compounds were found to show potent anticancer activity. Various substituents at C-2 and C-3 of thiazolidinone results in potent anticancer activity. Prompted by these reports, we aimed to prepare the following series of 2, 3-disubstituted-Thiazolidinone derivatives as potent anticancer agents.
This is the end of this tutorial post, and I hope it has helped your research about 2682-49-7. Electric Literature of 2682-49-7
Reference：
Quinuclidine – Wikipedia,
Quinuclidine | C7H414N | ChemSpider